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Abstract
Background Quality of life (QoL) is considered to be an
indispensable outcome measure of curative and palliative
treatment. However, QoL research often yields ﬁndings
that raise questions about what QoL measurement instru-
ments actually assess and how the scores should be
interpreted.
Objective To investigate how patients interpret and
respond to questions on the EORTC-QLQ-C30 over time
and to ﬁnd explanations to account for counterintuitive
ﬁndings in QoL measurement.
Methods Qualitative investigation was made of the
response behaviour of small-cell lung cancer patients
(n = 23) in the measurement of QoL with the European
Organization for Research and Treatment of Cancer Core
Quality of Life Questionnaire (EORTC QLQ-C30). Focus
was on physical functioning (PF, items 1 to 5), role
functioning (RF, items 6 and 7), global health and QoL
rating (GH/QOL, items 29 and 30). Interviews were held at
four points: at the start of the chemotherapy, 4 weeks later,
at the end, and 6 weeks after the end of chemotherapy.
Patients were asked to ‘think aloud’ when ﬁlling in the
questionnaire.
Results Patients used various response strategies when
answering questions about problems and limitations in func-
tioning,whichimpactedtheaccuracyofthescale.Patientshad
scores suggesting they were less limited than they actually
werebytakingthewordingofquestions literally,byguessing
theirfunctioninginactivitiesthattheydidnotperform,andby
ignoring or excluding certain activities that they could not
perform.
Conclusion Terminally ill patients evaluate their func-
tioning in terms of what they perceive to be normal under
the circumstances. Their answers can be interpreted in
terms of change in the appraisal process (Rapkin and
Schwartz 2004; Health and Quality of Life Outcomes, 2,
14). More care should be taken in assessing the quality of a
set of questions about physical and role functioning.
Introduction
Health-related quality of life (QoL) is considered to be an
important outcome for evaluating the impact of disease and
for assessing the effectiveness of treatment. QoL is partic-
ularlyrelevantforcancerpatientswhoarewillingtoundergo
risky and toxic treatment [1–4]. This is especially so in
patients with small-cell lung cancer (SCLC), for whom
therapy is unlikely to be curative and who receive life-pro-
longing and ‘palliative’ therapy. Understanding the burden
of symptoms and the relative effects of chemotherapy on a
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clinical practice for optimising the QoL of these patients
throughout the course of their illness [5].
However, QoL research often yields ﬁndings that raise
questions about what QOL measurement instruments
actually assess and how the scores should be interpreted.
For example, Groen et al. studied patients with inoperable
non-SCLC treated by radiation with and without chemo-
therapy [6]. QoL was measured with the European
Organization for Research and Treatment of Cancer Core
Quality of Life Questionnaire (EORTC QLQ-C30) [7],
which has been designed speciﬁcally for use in clinical
trials focusing on cancer patients. Contrary to expectations,
they found no signiﬁcant deterioration in the scores over
the 6-week treatment period. Patients with a life-threaten-
ing disease reported a stable QoL, and the level of QoL of
patients with a severe chronic illness was found to be no
worse or no better than that of less severely ill patients or
healthy people [8–14]. Furthermore, several studies show
that patients’ own evaluations may differ considerably
from those made by clinicians and signiﬁcant others
[15, 16]. Such ﬁndings, labelled by Breetvelt and Van Dam
as ‘under-reporting of problems’, suggest that patients
report less distress and dissatisfaction than they actually
experience [17]. In short, QOL measures do not consistently
distinguish illness experiences, they show little conver-
gence across measurement perspectives, and they are often
only weakly related to objective criteria, i.e., negative
factors such as side effects of chemotherapy have little
effect on the patients’s QoL (the so-called satisfaction
paradox) [18, 19].
In recent years the response shift theory has gained
increasing attention [20]. Response shift refers to a change
in a patient’s internal standards, values, and conceptuali-
zation of QoL. It is suggested that patients make the best of
their condition by coping, rethinking, and reframing their
experiences, and that this adaptive self-regulation may
explain these discrepancies [21–23].
In order to examine response shift more closely, we used
the EORTC-QLQ-C30 and the SEIQoL-DW (a patient-
centred measure to assess individual QoL) in a qualitative
exploratory longitudinal study involving 31 patients.
Recently, we reported our results on the measurement of
response shift with SEIQoL-DW (i.e., change in values and
conceptualization) [24, 25] and also our ﬁndings about how
patients dealt with the EORTC question ‘were you tired’
[26]. We found discrepancies between the levels of fatigue
as measured with the questionnaire and the levels sponta-
neously reported during the interview. These ﬁndings seem
to be in line with a study of Cox [27] who had studied
cancer patients who participated in a clinical trial; she
found no signiﬁcant change in the EORTC assessment, but
the in-depth interviews led to alternative conclusions about
the impact of the trial on these patients. What we learned
both from the literature and our own work is that respon-
dents are engaged in complex response patterns when
ﬁlling out a questionnaire. We argued that it is important to
know more about ‘what actually happens’ in QoL mea-
surement before trying to measure any response shift. This
paper describes the results of our longitudinal multiple case
study in which we investigated how patients interpret and
respond to questions on the EORTC-QLQ-C30 over time
and in which we focus on global health, global QoL
(GH/QOL), and items on the physical (PF) and role (RF)
functioning scales. This paper is a follow-up to this study
with the aim to search for explanations to account for the
above-mentioned ‘poorly understood’ QoL outcomes.
Methods
Procedures and study sample
In 2000, approval was obtained from the Medical Ethics
Committee of the VU University Medical Center for our
study, ‘‘Response shift in quality of life in the palliative
treatment of small-cell lung cancer patients’’. In March
2001 we started to recruit SCLC patients in ﬁve outpatient
clinics for chest diseases in the Netherlands. All patients
were evaluated for ﬁrst line chemotherapy, and no
restrictions were made with regard to age or treatment
(chemotherapy or a combination of chemotherapy and
radiotherapy). The participating patients gave written
informed consent and were interviewed during the treat-
ment trajectory. The ﬁrst interview was carried out within
7–10 days after diagnosis at the start of the chemotherapy.
In the original study design, the second interview was
planned after completion of the course of chemotherapy.
However, after the inclusion and ﬁrst interviews with three
patients, we decided that we would also interview the
patients during the treatment. Therefore, the second inter-
view was held 4 weeks after the ﬁrst interview, the third
7–10 days after completion of the chemotherapy treatment,
and the fourth interview 6 weeks after completion of
treatment.
Between March 2001 and September 2003, 41 eligible
patients were invited to participate in the study. Four
patients were unwilling to participate, and six were not
interviewed because of their imminent death. Of the 31
patients who were interviewed, eight were excluded from
the analysis because their data were incomplete, i.e., they
were only interviewed once (six died within a month after
the ﬁrst interview and two were too sick at the second and
died before the end of the planned chemotherapy). Con-
sequently, the ﬁnal study sample consisted of 23 SCLC
patients, 12 of whom were diagnosed with limited disease
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123(3 male and 9 female, mean age 55, range 42–69) and 11
with extensive disease (8 male and 3 female, mean age 64,
range 39–72). Except for seven patients whose chemo-
therapy was combined with local radiation of the tumour,
all patients received standard chemotherapy. The majority
of the patients were married (19, 83%) and had children
(17, 74%).
Of the 23 patients in our study sample, 15 were inter-
viewed four times, 7 were interviewed three times, and 1
patient was only interviewed twice, resulting in a total of
83 interviews. The interviews were conducted by MW with
a duration of 80–110 min. Except for the ﬁrst interview
with three of the patients, all interviews were held in the
patient’s home.
Materials and qualitative method
In this exploratory, longitudinal multiple-case study, QoL
was assessed with the EORTC QLQ-C30 (version 3.0) [7]
and the lung cancer module QLQ-CL13 [28]. The EORTC
QLQ-C30 is the cancer-speciﬁc QoL measurement instru-
ment that is most widely used in European clinical trials.
The questionnaire consists of several functioning scales
that measure, among other things, physical and role func-
tioning, mental and general health, and global QoL.
Furthermore, it measures different symptoms such as pain,
dyspnoea, nausea, and fatigue. For the questions about
functioning the respondent has four response options. The
respondent circles the most appropriate number, i.e., not at
all [1], a little [2], quite a bit [3], and very much [4].
General health and global QoL are rated by circling a
number between 1 and 7 (respectively, from very poor to
excellent). The QLQ-CL13 module measures the extent
to which patients experience symptoms or problems related
to their lung cancer, such as coughing and hair loss.
The EORTC QLQ-C30 and the CL13 were completed in
combination with the Three-Step Test Interview (TSTI) to
investigate how respondents interpreted the items and how
they responded to them [29]. The TSTI consists of the
following steps: (1) concurrent thinking aloud, aimed at
collecting observational data on how respondents complete
the questionnaire, expressing their thoughts aloud; (2)
focussed interview, aimed at clarifying the respondent’s
previous expression of thoughts while completing the
questionnaire; (3) semi-structured interview, aimed at
eliciting the respondent’s experiences and opinions with
regard to the questionnaire.
Interview protocol
In the ﬁrst interview, QoL was measured with the EORTC
QLQ-C30, followed by the lung cancer module QLQ-CL13.
The questionnaires were completed in a concurrent think
aloud manner, and after completion the respondents were
asked to clarify previous hesitations, and expressions when
rating certain items and experiences (i.e., second and third
step of the TSTI). Individual QoL was then measured with
the Schedule for the Evaluation of Individual Quality of
Life–Direct Weighting (SEIQoL-DW) [30, 31]. Finally, we
encouraged patients to talk freely about their experiences
withthetreatment.Atfollow-up(i.e.,atthesecond,thirdand
fourth interviews) the protocol of the ﬁrst interview was
extended with an extra QoL measurement, i.e., after the
SEIQoL-DW assessment, EORTC questionnaires were
completed again as a so-called ‘then test’ [32–34] (i.e., the
patients ﬁlled in these questionnaires according to how they
perceived themselves at the time of the previous interview).
In the second and following interviews, EORTC question-
naires (contemporary and then-test QoL assessment) were
also completed in a concurrent think-aloud manner. How-
ever, in contrast to the ﬁrst interview, we integrated the
second and third step of the TSTI in the assessments. In
actual practice this means that we encouraged patients to
thinkaloud,andweprobedforclariﬁcationaftereachitemif
extra information was considered to be useful in order to
understand the patient’s answers. We adopted a ﬂexible
approachinordernottointerruptthe naturalﬂowofboththe
assessment and the patient-interviewer communication.
Interviews were audio-taped and transcribed verbatim.
In this article we focus on the physical functioning scale
(PF, items 1 to 5), the role functioning scale (RF, items 6
and 7), and global health and QoL rating (GH/QOL, items
29 and 30).
Analysis
Four types of data were collected and used for the analysis
[35]: (1) completed questionnaires of all interviews, (2)
observed patient behaviour recorded in ﬁeld notes, (3)
transcriptions of the interviews, and (4) memos with
background information regarding the illness trajectory of
each patient. In order to manage the data of the interviews
(n = 83), we used the qualitative computer package
Kwalitan 5.0 (http://www.kwalitan.net) to extract relevant
parts of the transcriptions: (1) think aloud of the GH/QOL
questions and the functioning scales (i.e., physical and role)
and (2) ‘comments’ related to the way in which patients
were functioning, and the perceived impact of treatment on
QoL. Furthermore, in order to deal with the still remaining
large amount of extracted data, two of the authors
(MW, AT) condensed extracts from transcripts of the
‘comments’ into core texts. The data (e.g., think aloud
combined with scores and core texts of comments) were
organised and analysed for each patient separately, result-
ing in 23 case studies [36]. Initially, three authors (MW,
Qual Life Res (2008) 17:549–558 551
123AT, TH) independently analysed the data of the ﬁrst two
interviews of the ﬁrst patient. The aim was to understand
why a speciﬁc response category was chosen and to iden-
tify change in the response behaviour by comparing the
results of the two interviews. Further analyses of the 23
case studies were conducted by MW. She explored how the
patient had answered each item (i.e., interpretation of the
question, response, and choice of response category). She
interpreted the individual score and the think-aloud data of
that item against the background of the patient’s illness
trajectory and assessed whether that item had received a
score that one would expect if it truly reﬂected the limi-
tations the patient experienced. Finally she looked for
change in the process of appraising over time. Results were
discussed with AT and, after completing the individual
cases, MW and AT searched for patterns in the response
strategies for each item by examining similarities and
differences among the cases. The robustness of their
interpretations was critically discussed by the research
team (MW, AT, TH, MS).
Results
Quality of Life during ﬁrst line chemotherapy
For all patients, chemotherapy consisted of ﬁve cycles. After
the ﬁrst cycle (second interview, T2), 13 patients said that
theyweredoingwell,consideringthecircumstances.Patients
diagnosed with extensive disease who suffered from tumour-
related symptoms, such as dyspnoea and coughing, reported
feeling much better than before the treatment. Furthermore,
three of the seven patients who had been treated with che-
motherapy and radiation therapy experienced a severe
physical burden of the side effects of radiation therapy (e.g.,
pain, problems with eating and drinking, and consequent loss
of weight). All the patients experienced the impact of every
new cycle as more and more severe. Six weeks after the last
cycle, three patients had died, and two were confronted with
a recurrence of the cancer and further treatment. The others
attempted to pick up their normal life again.
According to the results of the EORTC-QLQ-C30, QoL
was affected very little by the chemotherapy (Table 1). The
mean values for GH/QOL at the start (ﬁrst interview, T1)
and at the end of the chemotherapy (third interview, T3)
were both 66. The mean value of the physical functioning
scale decreased from 75 at T1 to 72 at T3, but the mean
value of role functioning increased from 62 at T1 to 72 at
T3; seven patients had the highest possible rating (100),
and only one patient had the lowest possible rating (0).
We were not able to interview all 23 patients four times,
and therefore the mean values presented for the second and
fourth interview (i.e., T2 and T4) cannot be adequately
compared with the mean values for the ﬁrst and third inter-
view (i.e., T1 and T3). However, despite these differences
and the large individual variations, most of the patients
perceived their QoL to be at a higher level at the second
interview than at the ﬁrst (i.e., at the start of chemotherapy):
12 of19patientsreporteda higherlevelGH/QoL, 2an equal
level, and 5 a lower level of GH/QOL. Patients alsoreported
better QoL at6weeks afterthe course (T4) than at the endof
thecourse(T3):10of18patientsreportedahigherlevelGH/
QoL, 4an equal level, and 4 a lower level of GH/QOL. With
respect to the functional scales, the mean values of physical
and role functioning also increased 6 weeks after the course,
suggesting that most patients were not impaired by the
treatment: 8 of the 18 patients reported the highest level
(100) of role functioning and only 1 patient the lowest pos-
siblerating(0).InordertounderstandhowQoLoutcomesin
our study should be interpreted, background knowledge of
the response behaviour described below has to be taken into
consideration.
Patients’ answers at the ﬁrst QoL assessment
Questions 1 to 7 on the QoL instrument reveals important
clues to how patients report physical and role limitations.
Patients responded in unexpected ways: by focusing on one
aspect of the question, by taking the wording of the ques-
tion literally, and by ignoring or excluding certain activities
that they could not perform. This resulted in patients pro-
ducing QoL scores that suggested they were less limited
than they actually were (see Fig. 1 for examples). Fur-
thermore, a few patients guessed their level of functioning
in activities that they did not perform or used the strategy
‘‘I didn’t do it, so I don’t have any trouble’’ (example see
item 2), and a few compared present with previous expe-
riences (e.g., ‘‘I feel not too bad, compared to last week’’)
or with expectations (e.g., ‘‘I feel better as expected’’). The
following examples illustrate for each question how, during
the ﬁrst interview (T1), a certain strategy resulted in a
different QoL score than would be expected.
Item 1: Do you have any trouble doing strenuous activities,
like carrying a heavy shopping bag or suitcase? A patient
who could hardly walk outside the house answered this
question with ‘not at all’ by arguing that you can’t have any
trouble if you don’t do any shopping: ‘‘I never carry a
shopping bag, my wife does the shopping’’ [M, age 72, T1].
At T1, 17 out of 23 patients interpreted this item more or
less literally and focused on just shopping bags or suit-
cases: ‘‘I can lift the shopping bag but I can’t walk with it’’
or ‘‘my suitcase has wheels, so I don’t have to carry it’’.
Out of the other six patients, four were thinking about other
strenuous activities when evaluating this item, and two
were just circling the number that corresponded with
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for a longer time.
[These examples suggest that limitations were consid-
ered as ‘normal’ (MW)].
Item 2: Do you have any trouble taking a long walk? For
many patients this question was difﬁcult to answer, because
they had not taken long walks during the previous weeks.
Of 23 patients, 11 ﬁrst struggled with the deﬁnition of
‘long’ (which differed from 10 min to 2 h or from 500 m
to 10 km) and then they tried to guess their limitations:
‘‘What is a long walk, 5 km…? I never go for a long walk, I
don’t like serious walking, but I think I would be lim-
ited…a little?’’ [M, age 68, T1]. The other 12 mentioned a
recent walking experience, and most of them tried to guess:
‘‘I haven’t had a walk in the past weeks, so I don’t know,
but I walked with my son through the corridors in the
hospital and that went ﬁne. So, I haven’t tried…a little?’’
[F, age 69, T1], and two used the same strategy as men-
tioned earlier (i.e., I didn’t walk, so I don’t have any
trouble).
Item 3: Do you have any trouble taking a short walk out-
side of the house? Most patients seemed to have an image
of a short walk in their mind and circled without hesitation
a response category. Others remembered a recent experi-
ence: ‘‘A little, I’ve been to the shops at the end of the
street and that was enough for me’’ [F, age 64, T1].
Table 1 Individual and mean scores of patients answering the EORTC QLQ-C30 questions on physical functioning (PF), role functioning (RF),
and global health (GH) and quality of life (QOL)
Patient characteristics T1 (n = 23) T2 (n = 19) T3 (n = 23) T4 (n = 18)
No. M/F Age LD/ED GH/QOL PF RF GH/QOL PF RF GH/QOL PF RF GH/QOL PF RF
P 12 F 47 LD 83 100 100 100 100 67 66 100 67 83 93 33
P 04 F 50 LD 83 94 67 – – – 33 67 83 67 87 83
P 24 F 56 LD 83 100 50 75 93 100 92 93 67 100 100 100
P 17 F 64 ED 83 80 83 83 80 67 83 40 67 # # #
P 03 F 64 ED 83 67 33 – – – 58 40 0 50 60 33
P 34 F 51 LD 75 100 83 83 100 100 92 100 100 100 100 100
P 15 F 69 LD X* 75 93 83 50 60 67 42 80 67 83 93 100
P 01 F 42 LD X* 66 73 50 – – – 50 60 34 83 87 67
P 20 F 44 LD X* 66 87 100 42 73 0 42 80 50 33 47 0
P 32 F 60 LD 66 87 83 100 67 100 83 67 100 83 53 100
P 26 F 59 LD X* 58 42 56 92 93 100 75 92 83 – – –
P 08 F 69 ED 50 80 83 33 60 100 75 73 100 83 67 50
P 22 M 55 LD X* 75 73 67 83 75 67 50 60 100 – – –
P 21 M 69 ED 75 47 50 83 60 83 83 87 100 83 93 83
P 10 M 46 LD X* 66 87 67 83 87 67 83 93 83 83 93 83
P 09 M 66 ED 66 100 50 83 92 0 92 67 67 75 73 100
P 16 M 68 LD X* 66 67 100 75 73 67 58 67 67 75 87 100
P 18 M 72 ED 66 73 67 50 67 17 50 60 100 66 67 100
P 29 M 63 ED 50 80 50 50 80 67 58 83 33 75 87 100
P 27 M 69 LD 50 53 33 66 53 50 66 67 50 66 80 83
P 13 M 72 ED 50 53 33 66 60 67 66 60 67 42 67 33
P 02 M 57 ED 42 40 33 – – – 58 67 100 # # #
P 14 M 39 LD 33 53 0 66 73 83 58 60 67 # # #
All patients GH/QOL PF RF GH/QOL PF RF GH/QOL PF RF GH/QOL PF RF
Mean score 66 75 62 72 76 67 66 72 72 68 80 75
Small-cell lung cancer patients (n = 23), limited (LD) and extensive (ED) disease receiving 1st line chemotherapy were interviewed at equivalent
points in treatment: at start of chemotherapy (T1), 4 weeks later (T2), at end of chemotherapy (T3), and 6 weeks later (T4). Three patients died
before T4 (#). Scores range from 0 to 100; higher scores represent a higher level of functioning. Seven patients with limited disease were treated
with chemotherapy and radiation therapy (LD X*)
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123Item 4: Do you need to stay in bed or a chair during the
day? Many patients answered this question by laying the
stressononewordinparticular.Thisresultedinhigherlevels
offunctioningthanwouldbeexpected.Forexample,7outof
23 patients took the word ‘need’ very seriously and did not
report any limitation because ‘‘it’s not really necessary to
stay in bed or on a chair’’. Another patient interpreted the
word ‘need’ as being prescribed by the doctor. Because he
did not have such a prescription, his answer was ‘not at all’,
even though he spent most of the day in his bed [M, age 71,
T1]. Another six patients interpreted this question with an
emphasis on ‘staying in bed’, which they did not do during
theday.Althoughthesepatientssaidthattheytookanapora
restonaregularbasis,theydidnottakesittingonachairinto
account. The other half of the patients did not comment on
this item, but just circled the response category of their
choice.
Item 5: Do you need help with eating, dressing, washing
yourself, or using the toilet? One older male patient
considered the help that he received washing and dressing
as normal under the circumstances, and said: ‘‘No not at all,
I can do it by myself if I want to, I don’t really need help,
but at the moment I have less energy, and help from my
wife makes it easier for me’’ [M, age 72, T1]. Only two
patients needed help with eating, dressing, washing, and
using the toilet, all the other patients circled the response
category of their choice without further comments, or
saying that it was self-evident that they were not limited.
Item 6: Were you limited in doing either your work or other
daily activities? Most of the retired male patients (n =6 )
answered with ‘a little’ or ‘not at all’, arguing that they were
not working anymore and therefore not limited. All female
patients who did not have a job (n = 8) reported during the
ﬁrst interview the limitations they experienced in house-
work. The other nine who worked had taken sick leave, and
only three of them (i.e., two male patients with their own
business and one female patient with a part-time job) were
actually thinking about their job and reported limitations.
The other six ignored their work and focused on activities in
andaroundthe house: ‘‘Ican dosome workinthe house, like
sweeping the ﬂoor, so I’m not limited’’ [M, age 46, T1].
[These examples suggest that not working was consid-
ered as normal under the circumstances (MW)].
Item 7: Were you limited in pursuing your hobbies or other
leisure time activities? During the ﬁrst interview this
question was answered with ‘very much’ in some cases
when pursuing hobbies was not possible: ‘‘I always played
billiards with my friends. I could play at the moment but
I don’t, because then I’ll drink a couple of beers and that’s
not a good idea now’’ [M, age 39, T1]. Other patients
reasoned as mentioned earlier (i.e., I didn’t do it, so I’m not
limited): ‘‘I’ve not played the piano in the past few
weeks…no, not at all’’ [M, age 68, T1]. [The answer
suggests that the patient is feeling physically able to play,
but that he does not take into account the fact that his
illness might be the reason for not playing (MW)].
Fig. 1 Examples of response strategies used to answer question 1, 2,
4, 6, and 7 of the EORTC-QLQC30 questionnaire. These strategies
and change in the use of a certain strategy over time may explain why
patients do not report the deterioration in physical and role
functioning that would objectively be expected
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123Item 26: How would you rate your overall health during the
past week? Item 27: How would you rate your overall
quality of life during the past week?
Most patients circled a number between one and seven
in response to these items without much thinking aloud.
After they had completed these two questions the inter-
viewer asked them how they interpreted the questions.
Most patients deﬁned ‘overall health’ as how they were
actually feeling: ‘‘Overall health…, you’re not a healthy
person of course. Well it’s simple, you’re terminally ill, but
you’re not really feeling sick so…a5 ’ ’[M, age 39 at T1].
In evaluating ‘overall quality of life’, a few patients had
just circled a number that they thought appropriate, without
knowing what QoL meant. Most patients deﬁned ‘overall
quality of life’ as being able to do the things they want to
do: ‘‘I can’t do things as usual, watching television,
reading my paper, and going to the bookshop. Walking at
this moment is not possible…a4 ’ ’[M, age 72 at T1].
Change in patients’ answers
The variation in the interpretation and evaluation of the
different items described above was not only found
between patients, but also in the individual patient over
time. Change occurred especially in the sampling of
experiences when evaluating problems and limitations
concerning items 2, 6, and 7. These changes sometimes
resulted in scores suggesting that a patient was functioning
better than actually was the case, but we saw the opposite
as well. The following examples illustrate these variations
in patients’ answers.
Item 2: Do you have any trouble taking a long walk?
Nina was a women aged 69 (all names are pseudonyms).
Her scores indicated an equal level of functioning at both
assessments, which contrasted with her described ability to
walk at 6 weeks after her chemotherapy (T4) compared to 1
month after the start of her treatment (T2).
[T2] That’s very difﬁcult, to the shopping mall, 450 m,
quite a bit.
[T4] A long walk, 2 km, I walk too fast, it’s my own
fault, quite a bit.
[Her answers suggest that she changed her interpretation
of a long walk by adjusting the distance. This change can
also be interpreted as evidence of response shift, i.e., a
change in standards (MW)].
Item 6: Were you limited in doing either your work or other
daily activities? Ralph, married with children (age 46),
answered this question on both occasions with ‘a little’. His
scores suggest no change in role functioning. But his
concurrent think-aloud texts suggest an improvement.
[T2] A little, it depends how I’m feeling. If I have a good
day, I can take on the whole world. Vacuum cleaning,
my motorbike, my car’’.
[T4] A little, the ﬁrst day back at work again, the tension
having to tell everyone the same story over and over
again, but of course I feel much better than I did 6 weeks
ago.
[At T2 he ignored his job suggesting that taking sick
leave was normal. Six weeks after the course he was
actually thinking about his ﬁrst day at work and described a
much better state of health as before. Recalling different
experiences over time suggest that there was a change in
the patient’s perspective on ‘‘what was considered as
normal under the circumstances’’(MW)].
Item 7: Were you limited in pursuing your hobbies or other
leisure time activities? Like most patients, John (age 69)
felt ‘quite a bit’ limited in pursuing his hobby (gardening) at
theﬁrstinterview(T1).Inhisnextinterview,hisanswer(i.e.,
‘a little’) to the same question suggested an improvement,
while his concurrent think aloud shows no improvement at
all.
[T1] ‘‘My hobby is working in the garden, that’s very
difﬁcult, quite a bit’’.
[T2] ‘‘I’m reading at the moment. Gardening is not
possible anymore, a little’’.
[At both occasions he was thinking of his hobby
(i.e., gardening). However, his answer at the second inter-
view suggests an adjustment to his new situation (MW)].
Item 26: How would you rate your overall health during the
past week? Item 27: How would you rate your overall
quality of life during the past week?
We found no evidence of change in the patients’
deﬁnition of overall health. Overall health was consistently
interpreted as ‘‘how I’m feeling’’ (e.g., ‘‘Yes, you can’t miss
it. My health is a 7, it feels like a 7’’ [ F, age 57, T2].
Neither did we ﬁnd any change in the interpretation of
overall quality of life (i.e., ‘‘being able to do the things I
want to do’’), even in the case of a reoccurence of the
cancer and brain metastases (e.g., ‘‘it depends on my
contacts…that I can do my own things…a5i st ol o w …it
has to be a 6’’ [F, age 47, T4].
Discussion
The mean values of GH/QoL, physical (PF) and role (RF)
functioning scales during the treatment trajectory suggest
that SCLC patients had a good overall QoL and were
functioning largely without limitations, but we know from
interviews that these scores do not accurately reﬂect QoL
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123in SCLC patients. We found that the patients evaluated
QoL items concerning functioning against a standard of
what they perceived as normal under the circumstances and
that this standard changed when the circumstances and
their health changed. Our results also suggest that patients
redeﬁned what is important and what is no longer impor-
tant (e.g., work or hobbies that used to be important before
the diagnosis) through the course of treatment. These
ﬁndings are consistent with the occurrence of response
shifts during the illness trajectory.
Observing the QoL self-assessment by means of the
think-aloud procedure has provided us with insight into the
black box of what actually happens in repeated QoL mea-
surement. We have lifted the lid just for a little by listening
to the patient who is ﬁlling in the questionnaire. The phys-
ical and role functioning items appeared to have several
different interpretations, enabling a patient to give the
impression ofperforming well under the circumstances.Just
by ignoring certain activities that are mentioned in a ques-
tion, or by taking a question literally, patients are able to
maintain reasonable levels of functioning, if we are to
believe the EORTC data. Through this behaviour it seems
that, at a subconscious level, the patients are distancing
themselves from the meaning behind the question, i.e.,
measuring the impact of treatment and disease on their
functioning. If this is the case, the patients are presenting
their situation more positively than it actually is. Previously
[26] we found that, in addition to the response shift phe-
nomena, self-presentation is also a coping mechanism that
can explain discrepancies in the measurement of fatigue.
The aim of this studywas not to investigate whether patients
present a more positive image of themselves than they
experienceintheirday-to-daylife,butwaspredominantlyto
observehowpatientsinterpretandanswerthequestions,and
whether they change their way of answering. We found that
the patients did not deal with the questions in the way that
the researchers had intended. At face value, some questions
were also found to be unimportant, not applicable to the
patients’ situation, or not relevant at a certain point in time.
These ﬁndings are in line with Mallinson’s suggestion that
problems may arise when response options do not quite ﬁt
the questions, because there are no such response options as
‘I don’t do this’ or ‘I don’t know’ [37]. On the other hand,
the answers of patients who used the strategy ‘I can’t do this
anymore, so I’m not limited’ can also be interpreted as
evidence of response shift, i.e., reprioritization. Patients
make good and legitimate use of the opportunity the QoL
instrument provides to adjust the question to their own sit-
uation and consequently present an image of not being as
limited in functioning as one would expect.
Our ﬁndings conﬁrm what has been stated by Rapkin
and Schwartz [38], who acknowledge that counter-intuitive
ﬁndings might be explained by change in the appraisal
process: ‘‘QoL assessment induces a frame of reference
that depends upon the meanings an individual attaches to
questions. In responding to items, individuals necessarily
sample speciﬁc experiences within their frame of reference,
and each sampled experience is judged against relevant,
subjective standards of comparison. To arrive at a QoL
score, individuals must apply some combinatory algorithm
to summarize their evaluation of relevant experiences and
formulate a response’’. Changes in the perspective of
SCLC patients during their treatment trajectory, changes in
their sampling of experiences when evaluating an item, and
in the use of standards of comparison explain the variance
in QoL measurement at the individual level. Rapkin and
Schwartz propose a psychometric model of appraisal that
questions the existing methods for establishing the reli-
ability and validity of QoL assessment tools, and they
recommend that the assessment of appraisal should be
integrated into QoL research and clinical practice. The
results of our study show that knowledge about how
patients change their interpretation of questions is useful in
interpreting QoL data. Therefore, we agree with Rapkin
and Schwartz that research is needed to learn more about
the appraisal process. Our ﬁndings show how deﬁcient
items on this questionnaire are in terms of being able to
capture the complex response pattern that respondents
engage in when ﬁlling out the questionnaire. If the items on
role and physical functioning and the response options
provided lack the sensitivity or speciﬁcity to capture the
actual responses of the respondents, then this offers an
explanation of what has been discussed as discrepant
results. Following this line of argument positing a response
shift and an appraisal process will have to wait to see if
they are present after questions are (re)constructed so as to
properly capture the response patterns of the respondents.
More care should be taken in assessing the quality of a set
of questions to identify problems that result from mismatch
between the ‘theory’ underlying the questions and features
of a respondents actual behaviour and biography (29).
Conclusion
Terminally ill patients evaluate their QoL on question-
naires differently than they describe their QoL following
what we know to be debilitating chemotherapy treatment.
Changes in the appraisal process due to differences in the
frame of reference, the sampling of speciﬁc experiences,
and the standards of comparison used when rating items
explain how reported levels of physical and role func-
tioning and QoL are sustained under deteriorating physical
conditions. Background knowledge about the illness tra-
jectory and appraisal processes is therefore relevant for the
interpretation of QoL outcomes.
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